182 related articles for article (PubMed ID: 2655722)
1. Suppression of luteal estradiol receptors and progesterone synthesis by a gonadotropin-releasing hormone agonist (WY-40972) during midgestation.
Sridaran R; Mahesh VB
Biol Reprod; 1989 Feb; 40(2):276-82. PubMed ID: 2655722
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of a gonadotropin-releasing hormone agonist on the luteal synthesis of progesterone, estradiol receptors, and prolactin surges during early pregnancy.
Sridaran R; Ghose M; Mahesh VB
Endocrinology; 1988 Oct; 123(4):1740-6. PubMed ID: 3046924
[TBL] [Abstract][Full Text] [Related]
3. Effects of gonadotropin-releasing hormone treatment on ovarian steroid production during midpregnancy.
Sridaran R
Proc Soc Exp Biol Med; 1986 May; 182(1):120-6. PubMed ID: 3515349
[TBL] [Abstract][Full Text] [Related]
4. Changes in rat luteal ultrastructure and P450scc mRNA and protein content after in vivo treatment with a gonadotropin-releasing hormone agonist.
Smith CJ; Richards JS; Yasin K; Sangster JN; Sridaran R
Biol Reprod; 1991 Feb; 44(2):382-91. PubMed ID: 2009337
[TBL] [Abstract][Full Text] [Related]
5. Ovarian steroid production in rats treated with gonadotropin-releasing hormone during early pregnancy.
Sridaran R
J Steroid Biochem; 1987 Jan; 26(1):1-6. PubMed ID: 3546943
[TBL] [Abstract][Full Text] [Related]
6. GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy.
Sridaran R; Philip GH; Li H; Culty M; Liu Z; Stocco DM; Papadopoulos V
J Mol Endocrinol; 1999 Feb; 22(1):45-54. PubMed ID: 9924179
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone-agonist inhibits synthesis of nitric oxide and steroidogenesis by luteal cells in the pregnant rat.
Yang H; Bhat GK; Wadley R; Wright KL; Chung BM; Whittaker JA; Dharmarajan AM; Sridaran R
Biol Reprod; 2003 Jun; 68(6):2222-31. PubMed ID: 12606359
[TBL] [Abstract][Full Text] [Related]
8. GnRH action on luteal steroidogenesis during pregnancy.
Sridaran R; Lee MA; Haynes L; Srivastava RK; Ghose M; Sridaran G; Smith CJ
Steroids; 1999 Sep; 64(9):618-23. PubMed ID: 10503718
[TBL] [Abstract][Full Text] [Related]
9. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production.
Clayton RN; Harwood JP; Catt KJ
Nature; 1979 Nov; 282(5734):90-2. PubMed ID: 228197
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of steroidogenesis by luteal cells of early pregnancy in the rat in response to in vitro administration of a gonadotropin-releasing hormone agonist.
Srivastava RK; Luu-The V; Marrone BL; Harris-Hooker S; Sridaran R
J Steroid Biochem Mol Biol; 1994 May; 49(1):73-9. PubMed ID: 8003442
[TBL] [Abstract][Full Text] [Related]
12. Intraovarian localization of luteinizing hormone/human chorionic gonadotropin stimulation of testosterone and estradiol synthesis in the pregnant rat.
Sridaran R; Gibori G
Endocrinology; 1983 May; 112(5):1770-6. PubMed ID: 6832068
[TBL] [Abstract][Full Text] [Related]
13. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
Bramley TA; Stirling D; Menzies GS; Baird DT
Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
[TBL] [Abstract][Full Text] [Related]
14. Regulation of luteal cell lipoprotein receptors, sterol contents, and steroidogenesis by estradiol in the pregnant rat.
Gibori G; Chen YD; Khan I; Azhar S; Reaven GM
Endocrinology; 1984 Feb; 114(2):609-17. PubMed ID: 6317362
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of the bovine estrous cycle with a gonadotropin-releasing hormone analog.
Milvae RA; Murphy BD; Hansel W
Biol Reprod; 1984 Nov; 31(4):664-70. PubMed ID: 6439255
[TBL] [Abstract][Full Text] [Related]
16. Direct inhibitory effect of gonadotropin-releasing hormone upon luteal luteinizing hormone receptor and steroidogenesis in hypophysectomized rats.
Jones PB; Hsueh AJ
Endocrinology; 1980 Dec; 107(6):1930-6. PubMed ID: 6253282
[TBL] [Abstract][Full Text] [Related]
17. Dose-related actions of GnRH II analog in the cycling rhesus monkey.
Siler-Khodr TM; Yu FQ; Wei P; Tao SX; Coulhart S; Mactyszczyk S; Lui YX
Contraception; 2006 Aug; 74(2):157-64. PubMed ID: 16860054
[TBL] [Abstract][Full Text] [Related]
18. The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase.
Kohen P; Castro O; Palomino A; Muñoz A; Christenson LK; Sierralta W; Carvallo P; Strauss JF; Devoto L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3421-30. PubMed ID: 12843197
[TBL] [Abstract][Full Text] [Related]
19. Studies on the effect of gonadotropin-releasing hormone and its agonist on human luteal steroidogenesis in vitro.
Casper RF; Erickson GF; Yen SS
Fertil Steril; 1984 Jul; 42(1):39-43. PubMed ID: 6373386
[TBL] [Abstract][Full Text] [Related]
20. Expression of type I GNRH receptor and in vivo and in vitro GNRH-I effects in corpora lutea of pseudopregnant rabbits.
Zerani M; Parillo F; Brecchia G; Guelfi G; Dall'Aglio C; Lilli L; Maranesi M; Gobbetti A; Boiti C
J Endocrinol; 2010 Dec; 207(3):289-300. PubMed ID: 20880984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
